Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

Figure 3

Evolution of Ab to pegloticase and relation to pUox and pUA in three patients with a transient response to treatment with pegloticase. (A-C) Change during treatment in pUox (left vertical axis) and in the ELISAs for Ab to pegloticase (right vertical axis). (D) Change during treatment in pUA for the same three patients.

Back to article page